CAPTRUST Financial Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.6K | Buy |
+47,621
| New | +$98.6K | ﹤0.01% | 2374 |
|
|
2024
Q1 | – | Sell |
-51,102
| Closed | -$86.9K | – | 2381 |
|
|
2023
Q4 | $86.9K | Buy |
51,102
+33,390
| +189% | +$56.8K | ﹤0.01% | 2542 |
|
|
2023
Q3 | $18.2K | Sell |
17,712
-6,198
| -26% | -$6.38K | ﹤0.01% | 2523 |
|
|
2023
Q2 | $27.7K | Sell |
23,910
-1,642
| -6% | -$1.91K | ﹤0.01% | 2452 |
|
|
2023
Q1 | $38.6K | Buy |
+25,552
| New | +$38.6K | ﹤0.01% | 2226 |
|
|
2022
Q4 | – | Sell |
-21,198
| Closed | -$89K | – | 2118 |
|
|
2022
Q3 | $89K | Buy |
21,198
+20,631
| +3,639% | +$86.6K | ﹤0.01% | 1947 |
|
|
2022
Q2 | $2K | Sell |
567
-518
| -48% | -$1.83K | ﹤0.01% | 4466 |
|
|
2022
Q1 | $6K | Buy |
1,085
+564
| +108% | +$3.12K | ﹤0.01% | 4065 |
|
|
2021
Q4 | $5K | Sell |
521
-370
| -42% | -$3.55K | ﹤0.01% | 4068 |
|
|
2021
Q3 | $10K | Sell |
891
-103
| -10% | -$1.16K | ﹤0.01% | 3605 |
|
|
2021
Q2 | $15K | Buy |
994
+504
| +103% | +$7.61K | ﹤0.01% | 3305 |
|
|
2021
Q1 | $8K | Buy |
490
+390
| +390% | +$6.37K | ﹤0.01% | 3540 |
|
|
2020
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 3117 |
|
|
2020
Q3 | $2K | Sell |
100
-100
| -50% | -$2K | ﹤0.01% | 2766 |
|
|
2020
Q2 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 2512 |
|
|
2019
Q4 | – | Sell |
-1,396
| Closed | -$26K | – | 1360 |
|
|
2019
Q3 | $26K | Buy |
1,396
+1,196
| +598% | +$22.3K | ﹤0.01% | 1223 |
|
|
2019
Q2 | $4K | Hold |
200
| – | – | ﹤0.01% | 1694 |
|
|
2019
Q1 | $5K | Hold |
200
| – | – | ﹤0.01% | 1526 |
|
|
2018
Q4 | $5K | Hold |
200
| – | – | ﹤0.01% | 1327 |
|
|
2018
Q3 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 1330 |
|